Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
03:55pm, Tuesday, 04'th Feb 2025
NEW YORK , Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson. ("J&J" or the "Company") (NYSE: JNJ).
CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi
12:10pm, Tuesday, 04'th Feb 2025
The CHMP recommends approval for JNJ's subcutaneous formulation of Rybrevant in NSCLC and AstraZeneca's Imfinzi in limited-stage small-cell lung cancer.
Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference
04:30pm, Monday, 03'rd Feb 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 45th Annual TD Cowen Healthcare Conference on Tuesday, March 4th, 2025. Management will participate in a firesid
You Deserve Reliable Income: 2 Undervalued Dividends For Long-Term Growth
08:51am, Monday, 03'rd Feb 2025
A buy-and-hold strategy is ideal for investors seeking durable companies with strong dividends and attractive valuations, avoiding tax inefficiencies from frequent trading. UPS offers a 5.7% dividend
Is Johnson & Johnson Stock a Buy?
12:21pm, Sunday, 02'nd Feb 2025
Johnson & Johnson (JNJ -0.47%) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
10:00am, Saturday, 01'st Feb 2025
NEW YORK, NY / ACCESS Newswire / February 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson("J&J" or the "Company") (NYSE:JNJ). Such investors are advised to
Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?
07:30am, Saturday, 01'st Feb 2025
Johnson & Johnson (JNJ -0.47%) has a diverse healthcare business, and investors often look to it as a safe dividend stock to invest in for the long term. One area where it has been lacking, however, i
Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?
06:14am, Saturday, 01'st Feb 2025
Johnson & Johnson (JNJ -0.47%) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the vaunted, 30-company Dow Jones Industrial Average that year.
US government could seek over $1 billion from J&J for cancer treatment costs
05:12pm, Friday, 31'st Jan 2025
The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal health agencies' payments of medical costs for patients who allege that the
Why Johnson & Johnson's Strong Buy Rating Is Justified (Rating Upgrade)
05:03pm, Thursday, 30'th Jan 2025
On January 22, Johnson & Johnson released financial results for the fourth quarter of 2024, which beat my expectations again. So, sales of its oncology franchise reached $5.5 billion, an increase of 1
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
12:00pm, Thursday, 30'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson("J&J" or the "Company") (NYSE:JNJ). Such investors are advised to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
12:50pm, Tuesday, 28'th Jan 2025
NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson ("J&J" or the "Company") (NYSE: JNJ). Such investors are advised to conta
Two Sigma Sells These Stocks Amidst Departure of Billionaire Founders
10:45am, Tuesday, 28'th Jan 2025
Two Sigma Investments founders John Overdeck and David Siegel are worth an estimated $14 billion.
Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock
10:41am, Tuesday, 28'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Stocks Upgraded by Bank of America – Here's Why They're Bullish
07:45am, Tuesday, 28'th Jan 2025
The new trading year is getting started, and investors might be looking to make this one either as strong as 2024 was or even stronger yet. To do this, it is always preferred to start on a strong note
